However, the upregulation of QC has been confirmed to be involved in multiple diseases and abnormal conditions including neurodegenerative diseases, cancers, inflammation, etc. by catalyzing the generation of pE-modified mediators such as pE-Aβ and pE-CCL2. This evidence concerns the gene CCL2 and cancer.